BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6702130)

  • 1. [Prognostic significance of the lung lesions in lymphogranulomatosis].
    Simbirtseva LP; Gubareva AV; Sheĭdakov AA; Skripkina NS
    Vopr Onkol; 1984; 30(2):40-5. PubMed ID: 6702130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical characteristics of treatment-resistant forms of lymphogranulomatosis in children].
    Kolygin BA; Kobikov SKh
    Vopr Onkol; 1990; 36(7):841-5. PubMed ID: 2399666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of lymph nodes dissection of lung cancer treatment].
    Konaka C; Kato H; Sato M; Hiyoshi T; Saito H
    Kyobu Geka; 1994 Jan; 47(1):45-8. PubMed ID: 8277633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modality of failure following resection of stage I and stage II non-small cell lung cancer.
    Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G
    Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laparotomy in Hodgkin's disease: significance of splenic involvement].
    Tawil E; Mercier JP
    Can Med Assoc J; 1984 Jul; 131(2):115-8. PubMed ID: 6744158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic models for Hodgkin's disease].
    Panyshin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
    Vopr Onkol; 2006; 52(5):538-43. PubMed ID: 17168362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
    J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
    Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
    Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of intrapulmonary metastases in cases of surgically treated lung cancer].
    Szöke T; Troján I; Furák J; Tiszlavicz L; Balogh A
    Magy Onkol; 2003; 47(4):397-401. PubMed ID: 14716437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.